Biopharma Industry is Seeing Merit in Early Preclinical Strategies: The biopharma industry is seeing more merit in strategizing clinical and commercial drug development as early as the preclinical phase.
| Published in: | BioPharm International Vol. 34; no. 11; pp. 36 - 38 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Published: |
MJH Life Sciences
Nov2021
|
| Online Access: | View this record in EBSCOhost |